Comparison of Oncotype DX (ODX) and Mammostrat (MS) Risk Estimations and Correlations with Histologic Tumor Features in Low Grade, ER-Positive Invasive Breast Carcinoma (BC).

被引：0
|
作者：
Acs, G. [1 ]
Kiluk, J. [1 ]
Loftusi, L. [1 ]
Larongal, C. [1 ]
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P4-09-28
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-09-28
引用
收藏
页数：1
相关论文
共 11 条
  • [1] Comparison of Oncotype DX and Mammostrat risk estimations and correlations with histologic tumor features in low-grade, estrogen receptor-positive invasive breast carcinomas
    Acs, Geza
    Kiluk, John
    Loftus, Loretta
    Laronga, Christine
    MODERN PATHOLOGY, 2013, 26 (11) : 1451 - 1460
  • [2] The ZNF217 Biomarker Predicts Low- and High-Risk Oncotype DX® Recurrence Score in ER-Positive Invasive Breast Cancers
    Cohen, Pascale A.
    Loudig, Olivier
    Liu, Christina
    Albanese, Joseph
    Fineberg, Susan
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [3] Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast
    Hou, Yanjun
    Zynger, Debra L.
    Li, Xiaoxian
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 148 (02) : 167 - 172
  • [4] Comparison of risk stratification of ER-positive, node-negative breast cancer patients by Oncotype DX versus molecular grade index and HOXB13/IL17BR ratio
    Sgroi, D.
    Hameed, O.
    Hattab, E.
    Chang, B.
    Moulis, S.
    Steffel, L.
    Salunga, R.
    Ma, X.
    Erlander, M.
    Goss, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Computer extracted features of tumor grade from H&E images predict oncotype DX risk categories for early stage ER plus breast cancer
    Whitney, Jon R.
    Romeo-Bucheli, David
    Janowczyk, Andrew
    Ganesan, Shridar
    Feldman, Michael
    Gilmore, Hannah
    Madabhushi, Anant
    CANCER RESEARCH, 2018, 78 (04)
  • [6] Estimation of Risk of Recurrence of Early Stage Estrogen Receptor Positive (ER+) Breast Carcinoma (BC) by Pathologists Compared to Oncotype Dx Recurrence Score - A Multi-Institutional Study
    Acs, G.
    Esposito, N. N.
    Reynolds, C.
    Lawton, T. J.
    Bleiweiss, I.
    Nagi, C.
    Ioffe, O.
    Hameed, O.
    Dabbs, D.
    Bhargava, R.
    Quddus, M. R.
    Sung, C. J.
    Gilereast, M.
    Sapino, A.
    Cserni, G.
    Kulka, J.
    Jacquemier, J.
    Regitnig, P.
    Baas, I.
    van Diest, P.
    Quinn, C.
    LABORATORY INVESTIGATION, 2010, 90 : 32A - 32A
  • [7] Estimation of Risk of Recurrence of Early Stage Estrogen Receptor Positive (ER+) Breast Carcinoma (BC) by Pathologists Compared to Oncotype Dx Recurrence Score - A Multi-Institutional Study
    Acs, G.
    Esposito, N. N.
    Reynolds, C.
    Lawton, T. J.
    Bleiweiss, I.
    Nagi, C.
    Ioffe, O.
    Hameed, O.
    Dabbs, D.
    Bhargava, R.
    Quddus, M. R.
    Sung, C. J.
    Gilcreast, M.
    Sapino, A.
    Cserni, G.
    Kulka, J.
    Jacquemier, J.
    Regitnig, P.
    Baas, I.
    van Diest, P.
    Quinn, C.
    MODERN PATHOLOGY, 2010, 23 : 32A - 32A
  • [8] Prediction of Low versus High Recurrence Scores in Estrogen Receptor-Positive, Lymph Node-Negative Invasive Breast Cancer on the Basis of Radiologic-Pathologic Features: Comparison with Oncotype DX Test Recurrence Scores
    Dialani, Vandana
    Gaur, Shantanu
    Mehta, Tejas S.
    Venkataraman, Shambhavi
    Fein-Zachary, Valerie
    Phillips, Jordana
    Brook, Alexander
    Slanetz, Priscilla J.
    RADIOLOGY, 2016, 280 (02) : 370 - 378
  • [9] A novel 95-gene signature (Curebest 95GC Breast) that predicts recurrence-risk in patients with ER-positive, HER2-negative, node-negative, early-stage primary invasive breast cancer with an intermediate Oncotype DX Recurrence Score.
    Fujii, Takeo
    Masuda, Hiroko
    Cheng, Yee Chung
    Yang, Fei
    Sahin, Aysegul A.
    Naoi, Yasuto
    Matsunaga, Yuki
    Raghavendra, Akshara Singareeka
    Sinha, Arup Kumar
    Fernandez, Jose R. Espinosa
    James, Anjali
    Yamagishi, Keisuke
    Matsushima, Tomoko
    Tripathy, Debu
    Tada, Sachiyo
    Jackson, Rubie S.
    Noguchi, Shinzaburo
    Nakamura, Seigo
    Acoba, Jared David
    Ueno, Naoto T.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Prognostic significance of age, histologic subtype, tumor size and nodal status on breast cancer specific survival of "clinical low risk" grade 1 ER+/HER2-breast carcinoma patients - SEER analysis 2010-2012
    Orucevic, Amila
    Bell, John L.
    CANCER RESEARCH, 2021, 81 (04)
12